• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[健康人和肾病综合征患者尿液中酸稳定抑制剂(血浆α-间胰蛋白酶抑制剂代谢产物)的浓度]

[Concentration of acid-stable inhibitors--metabolites of plasma inter-alpha trypsin inhibitor--in the urine of healthy people and in patients with nephrotic syndrome].

作者信息

Ogloblina O G, Poliantseva L R, Paskhina T S

出版信息

Vopr Med Khim. 1984 Mar-Apr;30(2):104-8.

PMID:6204451
Abstract

Concentration of acid stable inhibitors (ASI)--metabolites of plasma inter-alpha-trypsin inhibitor--was measured in urine samples of healthy persons and of 6 patients with nephrotic syndrome by means of modified cross immunoelectrophoresis. There was obtained 2-25 mg of ASI (Mr 22,000 and 32,000) in diurnal urine samples of patients with nephrotic syndrome, which were 10-20 times higher as compared with these inhibitors level in the urine of healthy persons. The reverse correlation was established for the value of glomerular filtration and the lever of ASI (Mr 32,000) in the urine of patients with nephrotic syndrome.

摘要

采用改良交叉免疫电泳法,对健康人和6例肾病综合征患者的尿液样本中酸稳定抑制剂(ASI)——血浆α-胰蛋白酶抑制剂间代谢产物的浓度进行了测定。肾病综合征患者的日间尿液样本中获得了2-25毫克的ASI(分子量分别为22,000和32,000),与健康人尿液中这些抑制剂的水平相比,高出10-20倍。在肾病综合征患者的尿液中,肾小球滤过值与ASI(分子量32,000)水平呈负相关。

相似文献

1
[Concentration of acid-stable inhibitors--metabolites of plasma inter-alpha trypsin inhibitor--in the urine of healthy people and in patients with nephrotic syndrome].[健康人和肾病综合征患者尿液中酸稳定抑制剂(血浆α-间胰蛋白酶抑制剂代谢产物)的浓度]
Vopr Med Khim. 1984 Mar-Apr;30(2):104-8.
2
[Trypsin inhibitor in the urine of patients with glomerulonephritis].[肾小球肾炎患者尿液中的胰蛋白酶抑制剂]
Vopr Med Khim. 1988 Jan-Feb;34(1):89-94.
3
[Development of an immunoenzyme method for the quantitative determination of an acid-stable trypsin inhibitor in urine: use for assessing the severity of glomerulonephritis].[一种用于定量测定尿液中酸稳定型胰蛋白酶抑制剂的免疫酶法的开发:用于评估肾小球肾炎的严重程度]
Vopr Med Khim. 1990 Nov-Dec;36(6):79-83.
4
[Components of kallikrein-kinin system in the urine of patients with glomerulonephritis].[肾小球肾炎患者尿液中激肽释放酶-激肽系统的组成部分]
Vopr Med Khim. 1990 Jul-Aug;36(4):62-9.
5
[Urinary excretion of alpha-1-microglobulin and complement components in patients with chronic glomerulonephritis].[慢性肾小球肾炎患者α-1-微球蛋白及补体成分的尿排泄情况]
Przegl Lek. 1994;51(8):333-8.
6
Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.肾病综合征患者或接受持续性非卧床腹膜透析患者的抗凝血酶III缺失。肾病综合征患者尿液中存在无活性抗凝血酶III的证据。
J Lab Clin Med. 1987 May;109(5):550-5.
7
Urinary protein clearances in chronic renal diseases with and without uremia.伴有和不伴有尿毒症的慢性肾脏疾病中的尿蛋白清除率
Clin Chim Acta. 1967 May;16(2):253-7. doi: 10.1016/0009-8981(67)90189-1.
8
[A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].[慢性肾小球肾炎患者组织和血浆激肽释放酶尿排泄的底物抑制剂分析]
Urol Nefrol (Mosk). 1990 Jul-Aug(4):38-43.
9
Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.肾病综合征中纤溶蛋白和蛋白酶抑制蛋白的血浆水平及尿排泄情况。
J Lab Clin Med. 1994 Jul;124(1):118-24.
10
Investigation of inter-alpha-trypsin inhibitor and slow migrating proteinase inhibitors in serum and urine.血清和尿液中α-胰蛋白酶抑制剂及慢迁移蛋白酶抑制剂的研究
Dan Med Bull. 1991 Feb;38(1):68-77.